MoneyWorks4Me

Acutaas Chemicals - Quaterly Results

18 Oct 2025 Evaluate
The sales figure stood at Rs. 3051.93 millions for the September 2025 quarter. The mentioned figure indicates a growth of about 25.29% as compared to Rs. 2435.92 millions during the year-ago period.Profit for the quarter ended September 2025 rises by 93.46% to Rs. 728.91  millions from Rs. 376.78 millions.Operating profit for the quarter ended September 2025 rose to 1055.75 millions as compared to 567.09 millions of corresponding quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 3051.93 2435.92 25.29 5111.64 4147.29 23.25 9898.35 6875.83 43.96
Other Income 89.70 85.78 4.57 249.90 104.75 138.57 183.36 137.86 33.00
PBIDT 1055.75 567.09 86.17 1725.84 849.05 103.27 2434.78 1214.53 100.47
Interest 5.72 4.94 15.79 11.92 48.67 -75.51 58.57 58.94 -0.63
PBDT 1050.03 562.15 86.79 1713.92 800.38 114.14 2376.21 838.05 183.54
Depreciation 77.22 61.96 24.63 151.84 118.17 28.49 240.45 146.94 63.64
PBT 972.81 500.19 94.49 1562.08 682.21 128.97 2135.76 691.11 209.03
TAX 243.90 123.41 97.63 386.71 168.26 129.83 540.29 254.25 112.50
Deferred Tax 50.38 4.89 930.27 65.91 13.56 386.06 70.58 45.12 56.43
PAT 728.91 376.78 93.46 1175.37 513.95 128.69 1595.47 436.86 265.21
Equity 409.36 409.28 0.02 409.36 409.28 0.02 409.34 368.81 10.99
PBIDTM(%) 34.59 23.28 48.59 33.76 20.47 64.92 24.60 17.66 39.26
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..